Teddington, UK 10/12/17; Luxembourg 10/12/17—Life science and laboratory supplier LGC has agreed to sell its Forensics and Security division to lab testing firm Eurofins for an undisclosed amount. With €45 million ($49 million at €0.91 = $1) in revenue and 650 employees, the division provides forensic science services. “We are proud to have played a crucial role in the UK forensics landscape in the last two decades. During that time, LGC has invested significantly in improving the efficiency and effectiveness of delivering forensic evidence, with a very strong focus on quality and innovation,” said LGC CEO Tim Robinson. “I am confident that the business is set for a successful and exciting future under the global reach and scientific expertise of Eurofins.” The transaction is expected to close within the next few weeks.

LGC has invested in building its lab standards and genomics testing products portfolio in recent years with a series of acquisitions. This disposal may indicate a further shift toward lab products versus services. The company’s current divisions are Health & Pharma Solutions, Health Science and Innovation; Genomics; and LGC Standards.